36
Abstracts
Genetic variations drive the facial appearance. The ease of DNA
analysis can allow the clinician to add an additional aspect to
treatment planning. Including not only analysis for physiologic
and functional parameters, yet also familial/genetic data to
achieve long-term physiologic and surgical success.
This paper will review the history of cephalometrics and
its limited normative values; challenge whether planning (two-
dimensional or 3D) should be performed based on normative or
beautiful numerical analysis; and call together a community of
clinical and technical personnel to establish the next generation of
COGS.
Reference
1 Burstone, C. J., James, R. B., Legan, H., Murphy, G. A., & Norton, L. A.
(1978). Cephalometrics for orthognathic surgery.
J Oral Surg
,
36
, 269–277.
http://dx.doi.org/10.1016/j.ijom.2017.02.130Minimally invasive salivary gland therapy
M. McGurk
Guy’s Hospital, London, United Kingdom
In the past decade there has been a revolution in the treatment
of benign salivary gland disease. Despite that fact that in most
countries salivary gland adenectomy is the treatment of choice for
the management of salivary gland obstruction, ranulae and benign
tumours, this is no longer necessary.
A description of modern minimally invasive management tech-
nique will be provided. This will involve intra- and extracorporeal
lithotripsy and salivary endoscopy. The results of endoscope-
assisted surgical removal of over 200 submandibular and 100
parotid glands stones will be presented. New minimally invasive
techniques for the management of salivary ranulae with be dis-
cussed and the results over 1000 cases of extra capsular dissection
of parotid tumours will be presented.
http://dx.doi.org/10.1016/j.ijom.2017.02.131Management of temporomandibular joint-related progressive
facial asymmetries
P. Mehra
Boston University Henry M. Goldman School of Dental
Medicine, Boston, MA, United States
Progressive facial asymmetries often present many challenges for
clinicians. Achieving predictable functional and aesthetic results
in patients with facial asymmetries with orthognathic surgery
requires accurately diagnosing the aetiology responsible for the
dentofacial deformity. The role of the temporomandibular joint
(TMJ) in the development of progressive facial asymmetries can-
not be overemphasised; examples include joint conditions like
condylar hyperplasia and osteochondroma, both of which cause
mandibular overgrowth beyond the usual timeline for cessation
of lower jaw growth. This presentation will provide an overview
of the most common TMJ-related facial deformities and focus on
contemporary principles used in the surgical management of these
complex patients.
http://dx.doi.org/10.1016/j.ijom.2017.02.132Surgically-assisted orthodontic therapy: an office-based alter-
native for rapid correction of malocclusions
P. Mehra
Boston University Henry M. Goldman School of Dental
Medicine, Boston, MA, United States
Duration and cost of the treatment still remain the biggest
challenges for the orthodontic field in the current era. Typical
orthodontic treatment ranges from 1 to 2 years, which requires
continuous compliance and expense from the patient’s perspec-
tive for a considerable period of time. Although, a relatively new
technique, selective alveolar decortication (SAD) has the potential
to provide a solid platform for improvement in the efficiency and
effectiveness of current-day orthodontic therapy.
Besides increasing the scope of orthodontic treatment, it has-
tens the results of conventional nonsurgical orthodontic therapy
and has the potential to correct certain specific malocclusions
with minimally invasive, office-based surgery. This presentation
details experiences of over 100 patients with this technique and
aims to familiarise the audience with the biophysiology, surgical
considerations, indications, contraindications, and limitations of
SAD.
http://dx.doi.org/10.1016/j.ijom.2017.02.133Face transplant: long-term outcomes
J.P. Meningaud
University of Paris 12, France
Background:
Over 38 face transplantations have been performed
worldwide since 2005.
Objectives:
The aimof this studywas to give an update of the long-
term outcomes of a series of patients operated in our department
between 2007 and 2011.
Methods:
Outcomes of 7 face allotransplant recipients were
reported on average 6 years after transplantation. All hospi-
talisations except for planned revision surgeries and immuno-
suppressive follow-up therapy were reported as serious adverse
events (SAE). Patient health-related quality of life (HRQoL) was
assessed quantitatively using the Short Form-36 (SF-36) health
questionnaire.
Findings:
In all patients still alive after a long follow-up, the trans-
plants were functional. Of the 7 patients, 2 died: one, 63 days’
post-transplantation due to transplant destruction with concomi-
tant pseudomonas infection and the second by suicide after battling
depression. SAE were related to infection within the first month,
acute rejection from 1 day to 7 years’ post-transplantation, and
to side effects of immunosuppressive therapy. Recurrent rejection
episodes justified maintenance therapy with high-dose steroids in
all patients at the last follow-up visit, yet no patient developed
diabetes. Three patients developed hypertension and a treatment
was needed in one patient. In all patients, a significant reduction
in glomerular filtration rate was noted. All recipients and their
families well accepted their transplant. Improvements in social
integration and HRQoL were highly variable among patients and
depended on baseline levels and psychiatric comorbidities.
Conclusion:
These long-term outcomes highlight the significant
pre-existing psychiatric conditions on the risk/benefit ratio of
facial transplantation.
http://dx.doi.org/10.1016/j.ijom.2017.02.134




